Santa Ana Bio, Inc. Alternatives & Competitors
12 companies similar to Santa Ana Bio, Inc. — Precision medicines for serious immune mediated diseases.
Companies similar to Santa Ana Bio, Inc.
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
South San Francisco, Unit...
GlycoEra AG
Advancing Glycan Mediated Therapy
Wadenswil, Switzerland
Zymeworks Inc.
Developing novel medicines for patients with difficult-to-treat cancers and other serious...
Canada
Entelexo Biotherapeutics
Entelexo has created a novel platform technology for engineering exosomes as a new approac...
Irvine, United States
Rival Readout
Competing with Santa Ana Bio, Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Gracell Biotechnologies
A Member of the AstraZeneca Group
Shanghai, China
Artax Biopharma Inc
Developing oral first-in-class Nck blockers for the treatment of T cell mediated autoimmun...
HI-Bio: A Biogen Company
HI-Bio is a clinical-stage biotech company delivering targeted therapies for patients with...
South San Francisco, Unit...
Seismic Therapeutic
The Machine Learning Immunology Company
Watertown, United States
Sonoma Biotherapeutics, Inc.
Leading the Next Frontier of Cell Therapy
South San Francisco, Unit...
Applied Molecular Transport
We are committed to developing transformational biologic medicines to serve patients with...
South San Francisco, Unit...
Mirador Therapeutics
Redefining Immunology and Inflammation with Precision
Immunaeon
Connecting Today's Science to Tomorrow's Cures
Buffalo, United States
About Santa Ana Bio, Inc.
Santa Ana Bio, Inc., founded in 2022, is an innovative biotech venture based in the United States. The company is committed to creating precision medicines for serious immune mediated diseases. Harnessing its expertise in multiomics and protein engineering, Santa Ana Bio aims to develop precision biologics targeting se...
Development of precision therapeutics, Antibody drug conjugate engineering, Multi-omics platform for genomic data analysis, Research and development of biologics, Clinical trial and drug approval process
Medical professionals in immunology, Pharmaceutical companies, Biotech investors, Patients with autoimmune and inflammatory diseases, Healthcare providers
Precision Medicines, Immune Mediated Diseases, Multiomics Platforms, Protein Engineering, Precision Biologics, Autoimmune Diseases, Inflammatory Diseases, Cell Profiling Technologies, Antibody Engineering, Targeted Therapies, Biopharmaceutical Research
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Santa Ana Bio, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Santa Ana Bio, Inc. on 28 Jan 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 18 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
